NCT02077699 Lacticaseibacillus paracasei DG (CNCM I‑1572 / DSM 34154) & Irritable Bowel Syndrome (IBS)

Study overview

NCT02077699 Lacticaseibacillus paracasei DG (CNCM I‑1572 / DSM 34154) & Irritable Bowel Syndrome (IBS) is a non-randomized clinical phase IV treatment trial studying Lacticaseibacillus paracasei DG (CNCM I‑1572 / DSM 34154) in patients with Irritable Bowel Syndrome (IBS) (Rome III Diagnostic Criteria)

Primary outcome measures

Intensity of painful symptoms

Results

Published results could not be found as of February 2026